New device trial aims to seal off dangerous brain bulges
NCT ID NCT06761365
Summary
This study is testing the early safety and feasibility of a new medical device called the LuSeed Aneurysm Embolization System for treating unruptured brain aneurysms. The device is designed to be placed inside the aneurysm to block blood flow and prevent rupture. Up to 30 eligible patients at European medical centers will participate in this initial evaluation.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UNRUPTURED INTRACRANIAL ANEURYSM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Jan Mikulicz-Radecki University Clinical Hospital in Wrocław
NOT_YET_RECRUITINGWroclaw, Poland
Contact Email: •••••@•••••
Contact
-
Norbert Barlicki Memorial Teaching Hospital No. 1 of the Medical University of Lodz
RECRUITINGLodz, Poland
Contact Email: •••••@•••••
Contact
-
Sheba Medical Center
RECRUITINGTel Litwinsky, Israel
Contact Email: •••••@•••••
Contact
-
The University Medical Center Hamburg-Eppendorf
RECRUITINGHamburg, Germany
Contact Email: •••••@•••••
Contact
Contact
-
UCK Katowice
RECRUITINGKatowice, Poland
Contact Email: •••••@•••••
Contact
-
University Hospital St. Ivan Rilski
RECRUITINGSofia, Bulgaria
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.